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treatments, n = 17), Clinical effectiveness were assessed
with the Hamilton Anxiety Scale (HAMA17) by treatment
before and after 2 weeks, 4 weeks.
Results: Beginning at treatment Week2, the score of
the HAMA decreased gradually in the experiment group,
however there was no signiﬁcant difference in the score of
the HAMA between the 2 groups (P> 0.05), and the score of
the HAMA decreased more signiﬁcantly in the experiment
group by treating weeks 4. The score of the HAMA in the
control group change was signiﬁcantly higher than seen in
the experiment group (P< 0.05).
Conclusions: Transmetil has precise effectiveness in the
treatment for those patients with with depressed emotion
and Chronic liver failure in hepatitis B.
Table. Comparison of HAMA scores between two groups before and after
treatment
Group Before After treatment
treatment Week 2 Week 4
Experimental (n = 25) 13.34±3.86 10.54±4.11* 8.04±2.52**
Control (n = 13) 12.85±4.13 11.27±5.23* 11.89±3.78*
Data are the mean±SE, n = 38.
*P > 0.05, **P < 0.05 compared with treatment before; *P > 0.05, **P < 0.05
compared with the control group respectively.
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Aim: Our aim was to assess the feasibility of Methacetin
breath tests in decreasing mortality during or after liver
resection, predict complications and liver failure after
the resection. To the best of our knowledge there is no
study that checks liver function using Methacetin by oral
administration (indeed there is one study that uses IV
administration).
Method: Methacetin C13 breath test was kindly donated
by Beijing Richen Science and Technology Co., Ltd. 10
empty breaths were collected before each measurement
and 75mg/80ml methacetin was orally administered. After
administration 9 breaths at 10, 20, 30, 40, 50, 60, 80,
100 and 120 minutes were collected in the bags provided
by the manufacturer. Breath test was performed on the
day before operation, post operation days 1 and 10.
Patients with projected resection of more than 20% of the
liver were included in the study. Additional parameters
like liver enzymes, Child-Pugh score, platelets, albumin,
CT volumetry were assessed. Total of 42 patients were
included in the study, out of which 5 were healthy controls.
23 patients canceled operation because of insufﬁcient
liver function. 14 patients participated until the last
measurement of day 10 at National Cancer Center of
Mongolia. Three parameters of the methacetin breath test:
methacetin concentration after 30 min of administration
CUM30, highest concentration of methacetin DOB peak, and
calculated liver function using the software provided by the
manufacturer were obtained after each measurement.
Result: 5 healthy controls had the mean DOB peak value of
29.056, CUM30 of 91.56 and liver function 114.
When 20% of the liver was resected Methacetin
concentration was decreased by 47.09% (DOB peak), 72.1%
(CUM30), 63.22% (calc. liver function); when 35% resected
45.33%, 73.35%, and 74.28%; when 40% cut: 39.04%, 99.3%,
99.3%; when 50% cut 67.38%, 81.97%, 75.2%; when 65%
cut: values were 37.51%, 54.27% and 42.97% respectively.
All patients were Child-Pugh A, and mean albumin was
3.8 g/dl and platelets were 229×109/L, ALT 179IU/L and AST
162IU/L respectively. In terms of predicting complications
we observed DOB peak has the most meaningful results with
5 out of 6 patients with post operative complications had a
value of <20, while 6 out of 7 patients without complications
had values >20.
Conclusion: 3 parameters of the methacetin breath test
(methacetin concentration after 30 min of administration
CUM30, highest concentration of methacetin DOB peak,
and calculated liver function using the software provided
by the manufacturer) were compared the amount of liver
cut away. The closest parameter to the amount of liver
resected was the highest concentration of methacetin DOB
peak, whereas CUM 30 and liver function did not match
the amount as that of DOB peak. We suggest the cut off
value of DOB peak at 20. This method is non-invasive,
non-toxic, direct method to assess liver function with high
predictive and dynamic range in regard to residual liver
function. The sensitivity of the methacetin test to predict
post-operative complications were 83%, and the speciﬁcity
stands at 85% with PPV (Positive Predictive Value) = 83%,
and NPV (Negative Predictive Value) = 85% respectively. The
most common post-operative complications we encountered
were ascitis and wound infections.
Liver cirrhosis
Control
(n = 5)
Non cirrhosis
(n = 8)
Child Pugh
(n = 5)
DOB peak 29.06 25.29 18.56
CUM 30 91.56 94.01 64.32
Liver function 114 104.79 77.71
Complications after surgery
Control
(n = 5)
Complication
(n = 7)
Non complication
(n = 6)
DOB peak 29.06 26.56 18.21
CUM 30 91.56 89.84 74.12
Liver function 114 106.87 79.79
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Objectives: IGFBPrP1 was released at a continuous constant
dose by Alzet mini-osmotic pump which was implanted
subcutaneously of wild-type mice, Compare the effects
of IGFBPrP1 on liver and lung tissues and explore its
mechanism.
Methods: Mice were randomly divided into normal group,
sham-operated group and Operation group. We used
rmIGFBPrP1 which was released by capsule osmotic pump
to make the model. Sham-operated group was only treated
by control operation. HE and Picrosirius red staining were
used to evaluate pathomorphological changes and collagen
generation. The expression and distribution of IGFBPrP1,
Collagen-III, Smad3, p-Smad2/3 protein in mice hepatic and
lung tissues were tested by immunohistochemistry methods.
Apoptosis of hepatic cells was investigated by TUNEL.
